Flori P, Bellete B, Crampe C, Maudry A, Patural H, Chauleur C, Hafid J, Raberin H, Tran Manh Sung R
Pôle de Biologie-Pathologie, Laboratoire de Parasitologie et Mycologie, Hôpital Nord, CHU de Saint Etienne, France.
Clin Microbiol Infect. 2008 Mar;14(3):242-9. doi: 10.1111/j.1469-0691.2007.01905.x. Epub 2007 Dec 7.
A comparative evaluation of 384 selected sera was performed using the Beckman Coulter Access and Abbott Axsym Toxo-IgG assays. The Axsym assay yields positive early results following infection, while the Access assay gives higher titres during chronic infection. The ratio between the two complementary tests, Axsym Toxo-IgG/Access Toxo-IgG (Ax/Ac), was compared with the Vidas anti-Toxoplasma IgG avidity index (AI). The Ax/Ac ratio decreased progressively as the time between infection and sampling increased. The mean Ax/Ac values (+/-SE) were 2.50 (+/-0.26), 2.14 (+/-0.13), 2.33 (+/-0.22), 1.34 (+/-0.09), 1.32 (+/-0.10), 0.92 (+/-0.08) and 0.74 (+/-0.07) for groups of sera sampled at 1, 2, 3, 4-5, 6-8, 9-12 and 13-24 months, respectively, after infection in pregnant women. These values were much smaller for cases with chronic infection (>24 months), i.e., 0.56 (+/-0.03), 0.44 (+/-0.04) and 0.53 (+/-0.04), respectively, for pregnant women and immunodepressed patients with and without reactivation. Taking a ratio of 1 as a threshold for recent infection, the patients in the groups sampled at 1, 2 and 3 months had Ax/Ac ratios >1 in 49/50 (98%), 53/55 (96.4%) and 36/36 (100%) cases, respectively. Thus, an Ax/Ac ratio of <1 in serum from a pregnant woman allows a recent infection (<3 months) to be excluded. This technique has the advantage of yielding positive results that develop much more rapidly than the AI, thereby helping to reassure large numbers of pregnant women and avoiding costly and unnecessary prophylactic treatment and follow-up.
使用贝克曼库尔特Access和雅培Axsym弓形虫IgG检测方法对384份选定血清进行了比较评估。Axsym检测在感染后早期结果呈阳性,而Access检测在慢性感染期间给出更高的滴度。将两种互补检测方法Axsym弓形虫IgG/Access弓形虫IgG(Ax/Ac)的比值与Vidas抗弓形虫IgG亲和力指数(AI)进行比较。随着感染与采样之间时间的增加,Ax/Ac比值逐渐降低。孕妇感染后分别在1、2、3、4 - 5、6 - 8、9 - 12和13 - 24个月采样的血清组中,Ax/Ac的平均值(±标准误)分别为2.50(±0.26)、2.14(±0.13)、2.33(±0.22)、1.34(±0.09)、1.32(±0.10)、0.92(±0.08)和0.74(±0.07)。对于慢性感染(>24个月)的病例,这些值要小得多,即孕妇以及有和无再激活的免疫抑制患者的Ax/Ac值分别为0.56(±0.03)、0.44(±0.04)和0.53(±0.04)。以1作为近期感染的阈值,在1、2和3个月采样组中的患者,Ax/Ac比值分别在49/50(98%)、53/55(96.4%)和36/36(100%)的病例中大于1。因此,孕妇血清中Ax/Ac比值<1可排除近期感染(<3个月)。该技术的优点是产生阳性结果的速度比AI快得多,从而有助于让大量孕妇安心,并避免昂贵且不必要的预防性治疗和随访。